COVID-19   

Questions discussed in this category



Are you employing more or less primary chemoRT v. surgery for some cancers? Are you dose de-escalating? What are issues radiation oncologists should b...

I am considering every 6 week pembrolizumab dosing in patients >70 years old in whom I want to reduce clinic visits for, especially in the context ...

Would you consider it off-trial during the pandemic? There is some older data for treatment of pneumonia with single-fraction low-dose radiotherapy, w...

Any differences in the risks between SBRT vs. conventionally fractionation? Concurrent immunotherapy? 

How are you changing your parent/visitor policies?  Are you testing for COVID-19 in all febrile patients? Has COVID-19 changed the care settings...

For patients with low risk, early stage, hormone receptor positive, HER2 negative breast cancer who initiated endocrine therapy in order to delay thei...

Are you doing more TNT to prolong time to surgery? If so, do are you starting with CRT or chemotherapy?

What if the patient has a history of confirmed COVID-19 but has since recovered?

Our hospital is currently testing (PCR) for COVID-19 in all inpatients and outpatients undergoing surgical/"aerosolizing" procedures. Since radiation ...

Would you consider genomic assays before neoadjuvant chemotherapy? How would you modify your treatment given the COVID-19 pandemic?

I know many centers are exercising extra precautions in light of the new concerns with coronavirus. How are people explaining things to their patients...

Due to the apparent thrombogenic risk of COVID-19, would you consider holding tamoxifen in patients who test positive?

Please see this article for referrence https://www.sciencedirect.com/science/article/pii/S0167814020301638

What are the risks of infection with COVID-19 if using immunotherapy?  

For example, would you consider switching to an outpatient regimen in lieu of AIM for metastatic soft tissue sarcoma?

Many hormone positive patients are beginning hormone therapy until they can go to surgery. With a prolonged pause in routine procedures seeming very l...

Should staging and treatment decisions be made based on imaging alone?

Would the recommendation differ based on HR+ vs. TNBC vs HER2+ classification? Would you recommend against immediate breast reconstruction?

Given that majority of benefit is derived from the capecitabine, would this be an acceptable option to decrease patient contact with the healthcare sy...

How would you approach a patient who is receiving chemoRT but has confirmed COVID-19 with minor symptoms, as breaking treatment for 2 weeks quarantine...

Personally, my practice is to guide patients directly to surgery or to do neoadjuvant chemotherapy rather than to do neoadjuvant endocrine therapy, bu...

A case report (https://www.ncbi.nlm.nih.gov/pubmed/32149486) describes severe COVID-19 infection in a pediatric oncology patient. Have you seen simil...

If so, for how long would you expect this increased susceptibility to last? Our medical oncologists often tell patients that their lymphocyte counts m...

Are your practices adjusting priorities at this time? If so, what adjustments are you making? If not, do you have metrics in place that will tell you ...

Should the patient be admitted for observation which will risk exposing other immunocompromised patients to COVID-19, or should the patient be quarant...

When a physical exam is important and telehealth is not a good option, should we be proactive and reschedule or should we continue to see them as sche...

Mitigating the spread of COVID-19 is of utmost priority now that containment measures have failed. Social distancing will help "flatten the curve" of ...

Would you forego neoadjuvant chemotherapy? Are you using growth factor support differently? Any changes to immunotherapy? Other considerations?


Papers discussed in this category


Biotechnol. Prog., 2015 Mar 04

PLoS ONE, 2008 Jul 09

Public Health Rep,

Cochrane Database Syst Rev, 2011 Jul 06

Practical radiation oncology, 2019

BMJ (Clinical research ed.), 2010-03-02

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-01-01

Br. J. Cancer, 2013 Feb 05

Int. J. Radiat. Oncol. Biol. Phys.,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-06-10

Lancet Oncol., 2020 Mar 03

Lancet, 2020 Feb 07

JAMA Netw Open, 2020 Feb 05

Lancet Oncol., 2020 Feb 14

Ann. Oncol., 2020 Mar 26

Lancet, 2020 Mar 04

Intensive Care Med, 2020 Mar 03

Lancet, 2020 Jan 24

J Natl Cancer Inst, 1991 Mar 20

The New England journal of medicine, 1990-10-04

Pediatrics, 2020 Mar 16

Int. J. Radiat. Oncol. Biol. Phys., 2020 Jan 07

International journal of radiation oncology, biology, physics, 2014-03-15

Int. J. Radiat. Oncol. Biol. Phys., 2019 Feb 16

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-08-10

The New England journal of medicine, 2018-07-12

JAMA Oncol, 2019 Sep 30

J. Clin. Oncol., 2019 Jul 24

Radiation oncology (London, England), 2014-01-01

International journal of radiation oncology, biology, physics, 1980-02

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008-07-20

Breast J, 2019 Sep 09

The Lancet. Oncology, 2010-10

Breast Cancer Res. Treat.,

Lancet Oncol., 2013-10-01

Lancet Oncol., 2019 Jan 30

Annals of surgical oncology, 2016-05

Oncology, 2020 Jan 09

The New England journal of medicine, 2018-12-06

Lancet, 2019 Oct 04

British journal of haematology, 2016-06

Hum Exp Toxicol, 2019 May 06

Yale J Biol Med, 2013 Dec 13

Adv Radiat Oncol, 2020 May 05

Cancer Discov, 2020 May 01

Lancet, 2020 May 28

Int. J. Radiat. Oncol. Biol. Phys., 2020 Apr 14

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-06-20

Acta Paediatr., 2020 Mar 23

Pract Radiat Oncol, 2019 Dec 09

Radiother Oncol, 2010 Mar 23

International journal of radiation oncology, biology, physics, 2014-03-15

Ann. Oncol., 2019 Jun 13

The British journal of surgery, 2006-12

Br. J. Haematol., 2020 Apr 30

N Engl J Med, 2020 Apr 29